Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Quantum Biopharma Ltd. (V.QNT) had Pre-Tax Income of -18.87M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-18.61M |
|
-- |
|
-- |
|
-- |
|
-4.07M |
|
-- |
|
|
Pre-Tax Income |
-18.87M |
-18.87M |
|
-18.87M |
|
-18.87M |
|
-18.87M |
|
-18.87M |
|
-4.07M |
|
-3.90M |
|
4.49M |
|
4.49M |
|
-4.20 |
|
-4.20 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
20.48M |
|
-- |
|
-- |
|
-- |
|
22.43M |
|
-1.95M |
|
-8.00M |
|
-1.95M |
|
5.86M |
|
| Cash Flow Statement Financials | |
-2.29M |
|
-3.97M |
|
9.60M |
|
2.61M |
|
5.96M |
|
3.34M |
|
1.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.63 |
|
-- |
|
-- |
|
-- |
|
-0.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
968.64% |
|
235.94% |
|
-92.14% |
|
968.63% |
|
-0.33 |
|
-0.51 |
|
-0.51 |
|